A ballot measure that would raise billions for health research is drawing some unlikely foes in a race that has already ...

Second of Four Planned Modules Moves Rolling FDA Review Forward Advances Toward Targeted Completion of the Final Clinical ...

A second victim of the September 11 attacks has been identified with breakthrough genetic genealogy, which combines DNA ...

An assassin bug may look harmless, but its powerful venom can cause an incredibly painful bite and break down the tissues of ...

First Half Revenue Increased 6% to $10.9 Million; Gross Margin Expanded to 55%; Operating Income Increased 41%; Medical Market Sales Increased 289% Reiterates Expectation of Flat to Modest Revenue ...

Shares of Arrowhead Pharmaceuticals (NASDAQ:ARWR) leaped 6.7% on Wednesday after the biotechnology firm unveiled highly anticipated clinical data that could reshape the landscape of Alzheimer's ...

Project will begin with an H5N1 flu vaccine prototype and development of a vaccine platform framework for broader, safer, and ...

Spread the loveImagine a future where a debilitating disease, one that steals memories and identities, could be slowed, perhaps even halted, with just a few injections a year. For millions grappling ...

Spread the love“`html Imagine a world where a single treatment could potentially cure a debilitating chronic illness, not ...

A longitudinal study finds that older adults who recovered from COVID-19 mount weakened non-spike-specific Th1 CD4+ T cell ...

Remaining milestones: The company expects to submit two additional modules, including the final module containing clinical trial data, towards the end of the second quarter in 2027.

Age is just a number, and these ten Black entertainers prove that breakthrough success doesn't have an expiration date.